Cadrenal Therapeutics, Inc. operates as a clinical development biopharmaceutical company. The company focuses on developing Tecarfarin, a novel therapy with orphan drug indication for the prevention of systemic thromboembolism of cardiac origin in patients with end-stage renal disease and atrial fibrillation.
Cadrenal Therapeutics stock last closed at $13.86, down 7.54% from the previous day, and has increased 108.67% in one year. It has overperformed other stocks in the Biotechnology industry by 1.85 percentage points. Cadrenal Therapeutics stock is currently +143.16% from its 52-week low of $5.70, and -39.48% from its 52-week high of $22.90.
At the moment, there are 1.97M shares of CVKD outstanding. The market cap of CVKD is $27.26M. In the past 24 hours, 19,700 CVKD shares were traded.
How to Buy Cadrenal Therapeutics Stock
Wondering how to invest in Cadrenal Therapeutics stock? Here's how.
Choose where to buy Cadrenal Therapeutics stock: You need to decide on a stock brokerage, but don't worry - we've researched dozens of online stock brokerages and apps to help you determine where to buy Cadrenal Therapeutics stock.
Create your brokerage account: Sign up for 0% commission trading with the highest-rated brokerage we've found.
Deposit funds into your investment account: Pick your method of payment and add your details.
Evaluate Cadrenal Therapeutics stock: The Cadrenal Therapeutics ticker symbol is CVKD. Is Cadrenal Therapeutics stock a good investment? Should you buy shares of CVKD? How do CVKD's underlying business fundamentals look? Do top analysts think Cadrenal Therapeutics is a good buy? Why has CVKD's stock price moved recently? (Hint: Our stock market analysis tools can help you figure out if CVKD is a good stock to buy).
Place your CVKD purchase: Decide if you will purchase CVKD shares at the current market price or use a limit order to purchase CVKD stock at a particular price.
Watch your investment in CVKD: Create a watchlist to important notifications about your new investment in Cadrenal Therapeutics shares.
Step 1: Choose where to buy Cadrenal Therapeutics stock
You will need a brokerage account in order to access the NASDAQ market and buy CVKD stock.
A brokerage account is an investment account that enables you to buy and sell a number of investments, such as stocks, bonds, mutual funds, and ETFs.
Our preferred brokerage: eToro
In our opinion, eToro is the best online stock brokerage. eToro gives you:
You can invest in stocks with 0% commissions: Invest without paying trading commissions.
Buy fractional shares: Even if you don't have the money to buy a full share, you can still invest in the stock.
Access to global markets: From Technology to Real Estate, New York to Shanghai (for US users, only US stocks are available) — you can fill your portfolio with stocks from the world's top exchanges.
Social investing: eToro offers a community of more than 20 million users around the world. Talk to, learn from, and copy the unique crypto portfolios of top investors.
Security: eToro is a regulated and licensed fintech leader.
Buy other financial assets: Such as ETFs and cryptos.
Get $10 towards your purchase of shares by opening an account with eToro now. This offer is only for US users.
eToro securities trading is offered by eToro USA Securities, Inc. (“the BD”), member of FINRA and SIPC. Cryptocurrency is offered by eToro USA LLC (“the MSB”) (NMLS: 1769299) and is not FDIC or SIPC insured. Investing involves risk, and content is provided for educational purposes only, does not imply a recommendation, and is not a guarantee of future performance. https://www.wallstreetzen.com is not an affiliate and may be compensated if you access certain products or services offered by the MSB and/or the BD.
Step 2: Create your brokerage account
Now that you've chosen the right brokerage, the next step is to fill out some personal details so you can buy CVKD today.
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
Step 4: Evaluate Cadrenal Therapeutics stock
Once you have selected the best place to buy Cadrenal Therapeutics stock, it's absolutely critical to evaluate their stock before you invest, so you truly comprehend the risk and upside.
Overview of key CVKD info
CVKD Price
$13.86
1w %
-8.21%
1y %
108.67%
5y %
N/A
P/E
-1.5x
P/B
4.46x
P/S
N/A
PEG
N/A
Revenue
$0.00
Earnings
-$12.83M
Fore. Rev. Growth
N/A
Fore. Earn. Growth
N/A
Market Cap
$27.26M
Next Earnings
N/A
Next Dividend
N/A
CVKD Due Diligence Checks
WallStreetZen was designed to help part-time investors do more in-depth fundamental analysis quickly.
No, Cadrenal Therapeutics doesn't provide an income stream by paying out dividends.
What do other traders have to say about CVKD?
One of the major reasons eToro is our highest-rated brokerage is because of its social trading community.
Click below to learn what other community members have to say.
Step 5: Place your CVKD purchase
You have two primary types of orders:
Market order: A market order is an order to buy or sell a security at the best price on the market. Market orders are mostly fine for most investors.
Limit order: A limit order lets you buy or sell a stock at a specific price (or better). If you want to ensure you're buying or selling at a given dollar amount limit, place a limit order.
Press the Open button and your broker will execute the order.
If you require more help with buying stocks on eToro, watch the helpful video below:
How much does it cost to buy one Cadrenal Therapeutics share?
As of Jun 13, 2025, it costs $13.86 to buy one share of Cadrenal Therapeutics stock.
Remember, eToro's fractional share buying allows you to buy partial shares of stocks and ETFs. Even if you only have $6, you can buy 0.433 shares of CVKD.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.